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ABSTRACT
Background: Candida esophagitis is a common abnormality found on esophagogastroduodenoscopy (EGD) 
procedure in patients with recognizable risk factors. However, the finding is frequently incidental as most of 
them are asymptomatic. There has been no study on the characteristics of Candida esophagitis in Indonesia. 
The aim of this study was to describe the degree of Candida esophagitis and its characteristics in patients who 
underwent EGD procedure at Cipto Mangunkusumo Hospital.
Method: A retrospective study was conducted on all EGD procedures at the Gastroenterology Procedure 
Room, Internal Medicine Department, Cipto Mangunkusumo Hospital, between January 2007 and December 
2009 with a total of 2,311 samples. The study was carried out by visually examining all endoscopic procedures 
and grading them according to the Kodsi severity grading (1976), and evaluating medical records. Data analysis 
was performed using Microsoft Excel 2007.
Results: During the study period, Candida esophagitis was found in 2.6% patients with predominant male 
(68.9%) and the average age was 49.8 ± 15 years. The chief complaints found were dyspepsia (34.4%), melena 
(21.3%) and dysphagia (4.9%) and 32.8% patients were asymptomatic. The most frequent risk factors were age 
≥ 60 years old (28.3%), proton pump inhibitor or H2 receptor antagonist user (26.4%), and antibiotics (17.0%). 
Grade II Kodsi candidiasis was the most prevalent degree in this study (44.3%).
Conclusion: Candida esophagitis was one frequent finding in endoscopy based on the complaint of dyspepsia 
in patients with certain risk factors. However, the results of this study still need further validation in prospective 
studies.
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ABSTRAK 
Latar belakang: Esofagitis kandida merupakan salah satu kelainan yang sering ditemukan pada pasien 
dengan faktor risiko tertentu pada pemeriksaan esofagogastroduodenoskopi (EGD). Temuan ini seringkali 
insidental karena pada kebanyakan kasus tidak bergejala, namun hingga saat ini belum ada penelitian mengenai 
karakteristik esofagitis kandida di Indonesia. Tujuan dari penelitian ini adalah untuk mendeskripsikan derajat 
esofagitis kandida dan karakteristiknya pada pasien yang menjalani pemeriksaan EGD di Rumah Sakit Cipto 
Mangunkusumo (RSCM). 
Metode: Penelitian ini merupakan studi retrospektif yang dilakukan pada semua pasien yang menjalani 
pemeriksaan EGD di ruang prosedur endoskopi saluran cerna RSCM antara Januari 2007 hingga Desember 
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2009 dengan melibatkan 2.311 sampel. Semua hasil prosedur endoskopi diperiksa secara visual untuk kemudian 
dikatagorikan berdasarkan derajat keparahan Kodsi (1976). Analisis data dilakukan dengan menggunakan 
program Microsoft Excel 2007. 
Hasil: Selama periode penelitian, esofagitis kandida ditemukan pada 2.6% dari keseluruhan sampel dengan 
proporsi terbanyak pada laki-laki (68.9%) dengan rerata usia 49.8 ± 15 tahun. Keluhan terbanyak pasien adalah 
dispepsia (34.4%), melena (21.3%), dan disfagia (4.9%). Sebanyak 32.8% pasien dilaporkan tidak bergejala. 
Faktor risiko utama yang ditemukan adalah usia ≥ 60 tahun (25.8%), pengguna penghambat pompa proton atau 
antagonis reseptor H2 (24.1%) dan antibiotik (15.5%). Derajat esofagitis kandida terbanyak pada penelitian 
ini adalah derajat II Kodsi (44.3%).
Kesimpulan: Esofagitis kandida merupakan salah satu kelainan yang sering ditemukan pada endoskopi 
berdasarkan keluhan dispepsia pada pasien dengan faktor risiko tertentu. Hasil penelitian ini masih membutuhkan 
validasi lebih lanjut menggunakan studi prospektif.
Kata kunci: esofagitis kandida, endoskopi gastroduodenal, faktor risiko, derajat keparahan
INTRODUCTION
Candida esophagitis is one of the most frequent 
abnormalities found on esophagogastroduodenoscopy 
(EGD) as Candida, especially Candida albicans, is 
normally found in the throat.1 It is a common disease 
with a broad spectrum of severity, ranging from 
asymptomatic to severe symptoms, which may cause 
inability to eat and dehydration.2,3 These findings 
are frequently incidental in nature, because a lot of 
patients with Candida esophagitis present without any 
symptoms. The prevalence cited from a series of study 
shows that 20% of normal healthy adults and up to 
40% of immunocompromised patients were reported 
asymptomatic. Constitutional findings, including fever 
occur occasionally.4 As the infection become more 
severe, clinical features like odynophagia may develop, 
as well as other symptoms such as dysphagia, chest 
pain, epigastric pain and hemorrhage.1-4
Although the cases might often be found incidentally, 
patients with Candida esophagitis usually have several 
recognizable risk factors. With the increased usage of 
immunosuppressive agent for chronic inflammatory 
diseases and chemotherapy along with the acquired 
immune deficiency syndrome (AIDS) epidemic and 
other immunocompromised conditions such as diabetes 
mellitus, esophageal infections with Candida species have 
become relatively common.1 In addition, some studies 
have discovered several risk factors in developing Candida 
esophagitis, including carcinoma, proton pump inhibitor 
or H2 blocker usage, age above 65 years old, prior use of 
antibiotics, uncontrolled diabetes mellitus, and long term 
corticosteroid therapy, chronic renal failure, and inhaled 
corticosteroid.5,6 Although rare, infectious esophagitis 
also occurs among the non-immunocompromised, with 
Candida albicans being the most common pathogen.1
The severity of Candida esophagitis was described 
by Kodsi through his study involving 27 cases in 1976.7 
Despite of the variety of clinical presentations and its 
severity, until now, there was no study available on 
the characteristics of patients with Candida esophagitis 
in Indonesia as well as the severity of the disease. 
The aim of this study was to describe the degree 
of severity of Candida esophagitis, along with its 
characteristics in patients who underwent EGD 
procedures at Cipto Mangunkusumo Hospital.
METHOD
A retrospective analysis of all patients who 
underwent EGD procedure at the Gastroenterology 
Procedure Room in Internal Medicine Department, 
Cipto Mangunkusumo Hospital was carried out by 
visually examining all endoscopic procedures between 
January 2007 and December 2009. Patients with 
incomplete medical status and could not be traced 
were excluded. There were a total of 2,311 samples 
obtained during the study period according to inclusion 
and exclusion criteria. Medical records of patients 
with Candida esophagitis were reviewed to identify 
potential risk factors for the infections as well as the 
clinical symptoms at time of presentation, diagnosis 
and the severity grading.
Candida esophagitis was endoscopically diagnosed 
when typical candidal plaques were identified. To describe 
the severity of Candida esophagitis, a grading scale 
described by Kodsi was used. According to endoscopic 
appearance, Kodsi classified Candida esophagitis into 
four categories. Type I cases refer to a few whitish or 
beige plaques up to 2 mm in diameter without ulceration. 
Type II plaques are greater than 2 mm in diameter and 
more numerous. In milder grades, plaques may be 
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hyperemic or edematous, but there is no ulceration. 
Type III plaques may be confluent, linear, nodular, and 
elevated with hyperemia and frank ulceration, and type 
IV plaques are Type III plaques which additionally have 
increased friability of the mucosa and narrowing of 
the lumen.4,8 Statistical analysis of the compiled data from 
visual examination and medical records was performed 
by using Microsoft Excel 2007.
RESULTS
Throughout the study period, a total number of 
patients who underwent EGD procedures were 2,311 
patients. Based on the visual examination during 
endoscopy, Candida esophagitis was found in 61 cases 
(2.6%), with the majority of male patients (68.9%). 
The patients in this study ranged in age between 22 
and 79 years with 28.3% patients at over 60 years 
of age. When the underlying disease was taken into 
account, chronic kidney disease was found to be the 
largest proportion among the patients with Candida 
esophagitis (50%). Based on the Kodsi endoscopic 
grading, this study revealed that Grade II was the most 
prevalent severity. The summary of patient characteristics 
can be seen in Table 1.
Table 2 showed the noted patients’ clinical 
complaints when the EGD procedures were carried 
out. There were 32.8% patients who did not have 
any complaints. The main clinical manifestation was 
dyspepsia, which was found in 21 patients, followed 
by melena and dysphagia.
DISCUSSION
The prevalence of Candida esophagitis in Cipto 
Mangunkusumo Hospital is 2.6%. This proportion 
varies when compared with the population of other 
countries. A study in Brazil by Klieman et al, described 
that the prevalence of Candida esophagitis was 0.8% 
(n = 163). Their data was obtained from 21,248 upper 
gastrointestinal endoscopies that were carried out in 
18 months.6 Through a 6-year-duration of retrospective 
study in Saudi Arabia, Al Mofleh et al demonstrated 
that the prevalence of Candida esophagitis was 1% 
(n = 59) as evaluated from 5,028 upper gastrointestinal 
endoscopies.9
In this study, we found that a large proportion of 
patients were asymptomatic (32.8%). A retrospective 
study in Saudi Arabia showed that the prevalence 
of asymptomatic candidiasis reached 70% of the 
population.9 In candidiasis patients, alterations in 
cellular immunity may lead to candidal colonization 
and superficial infection; while humoral immunity 
prevents invasive disease and dissemination.3 
Therefore, despite the vast numbers of yeast involved 
in the infection, systemic dissemination rarely occurs 
in immunocompetent individual.2
Table 1. The characteristics of patient with Candida esophagitis
Variable n (%)
Age (years)













Solid tumor 1 (2.0)
Risk factors
Age > 60 years 15 (28.3)
PPI/H2RA 14 (26.4)
Prior antibiotic use 9 ( 17.0)
CKD 6 (11.3)
Chronic steroid usage 3 (5.7)
Solid tumor 2 (3.8)
DM 2 (3.8)
Steroid inhalation 1 (1.9)
Cytostatics 1 (1.9)
Kodsi grading
Grade I 12 (19.7)
Grade II 27 (44.3)
Grade III 15 (24.6)
Grade IV 7 (11.5)
CKD: chronic kidney disease; DM: diabetes mellitus; SLE: systemic lupus 
erythematous; PPI/ H2RA: proton pump inhibitor/H2 receptor antagonist
Table 2. The degree of clinical severity and endoscopic grading
Clinical manifestation n (%) Kodsi endoscopic grading (n = 61)Grade I Grade II Grade III Grade IV
Without complaint 20 (32.8) 3 10 6 1
Dysphagia 3 (4.9) 0 0 1 2
Melena 13 (21.3) 3 6 2 2
Dyspepsia 21 (34.4) 5 9 6 1
GERD 1 (1.6) 1 0 0 0
Dysphagia and vomiting 1 (1.6) 0 1 0 0
Odynophagia and disphagia 1 (1.6) 0 0 0 1
Dyspepsia and GERD 1 (1.6) 0 1 0 0
GERD: gastroesophageal reflux disease
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Candida esophagitis is a common opportunistic 
infection in patients with HIV since their level of 
immunity is a primary risk factor for the disease.2,3 
Approximately 10-15% patients with AIDS will suffer 
from this disease during their lifetime.10 Among patients 
with HIV infection who have esophageal symptoms, 
Candida is the most common identifiable pathogen on 
endoscopy, which is affecting up to 50% of patients.2 
However, no patient in this study was infected by 
the pathogen. The most common underlying disease in 
this study was chronic kidney disease. Immune defects 
in end-stage renal diseases may be related to metabolic 
and nutritional abnormalities, which probably impair 
both cellular and humoral immunities. In chronic renal 
failure, dialysis patients have increased risk of fungal 
infection, with candidiasis (79%) as the dominant 
etiology of fungal infection in chronic dialysis patients.11
Old age (> 60 years) is the most common risk factor 
in this study. One of our literatures showed that age over 
60 years may predispose to candidal infection through 
defective cellular immunity.12 This study revealed 
that 8 patients (13.1%) did not have any risk factor 
for esophageal candidiasis. It has been described that 
esophageal candidiasis could occur in immunocompetent 
individual. The mechanism might be related to 
the Candida strain virulence. It is generally said that most 
strains causing the disease are commensal in the patient; 
however, there are regulatory events that may switch 
the organism from a benign commensal to an invasive 
state.13 A case report showed that an immunocompetent 
pediatric patient may suffer from Candida esophageal 
perforation even without instrumentation or any surgical 
intervention, except from the chronic gastroesophageal 
reflux.14 Moreover, some reports of immunocompetent 
adults with esophageal infection suggest that 
the possible mechanism includes injuries to the 
esophageal ephitelium.14,15
The most frequent complaint of patients with 
Candida esophagitis in this study was dyspepsia 
(34.4%). It was discovered in every grade of Candida 
esophagitis, with the greatest proportion of grade I. 
Similar result was also found in a study in Pakistan 
demonstrating that epigastric symptoms were present 
in 35.3% patients with Candida esophagitis.5 
Based on that, a raised suspicion of esophageal 
candidiasis is appropriate for patients presenting 
symptoms of dyspepsia with risk factors, especially 
with visible oropharyngeal candidiasis. It is well stated 
that oropharyngeal candidiasis is commonly associated 
with esophageal candidiasis in immuno-compromised 
as well as non immunocompromised patients.2,3
It should be noted that, because of the restrospective 
nature in this study, some data may be missing, 
particularly regarding the patients’ complaints. 
In addition, it is a study reporting a prevalence which 
does not show any corelation between symptoms and 
the severity grading. Furthermore, it did not examine 
the risk factors statistically using multivariate analysis. 
Moreover, the biological importance of this study 
is unknown. However, this study provides clinical 
importance by suggesting that Candida esophagitis 
should be considered in patients who had recognizable 
risk factors and underlying diseases, including patients 
who presented with dyspepsia and other upper 
gastrointestinal symptoms. Therefore, further evaluation 
and EGD procedures can be carried out in time among 
these patients. Prospective studies on the association of 
patient characteristics and the severity grading should 
be carried out to further validate the results. 
CONCLUSION
Candida esophagitis is one of the most frequent 
findings in patients with certain risk factors and 
a complaint of dyspepsia who undergo endoscopic 
procedures. However, immunocompetent patients 
might show no typical symptom of esophagitis. 
The results of this study would still need further 
validation in prospective studies.
ACKNOWLEDGEMENT
The author would like to acknowledge a particular 
gratitude to all of the contributors in this study, 
including dr. Laras Budiyani as the manuscript 
developer. 
REFERENCES
1. Kahrilas PJ, Hirano I. Diseases of the esophagus. In: 
Longo D, Fauci A, Kasper D, Hauser S, Jameson L, 
Loscalzo J, eds. Harrisons’s Principles of Internal Medicine. 
18th ed. USA: McGraw-Hill 2011.p.2436.
2. Wilcox CM. AIDS & the gastrointestinal tract. In: Friedman 
S, McQuaid KR, Grendell JH, eds. Current Diagnosis & 
Treatment in Gastroenterology. 2nd ed. Singapore: McGraw-
Hill 2003.p.35-7.
3. Pegram PS. Esophagitis in immunocompromised host. 
In: Castell DO, Richter JE, eds. The Esophagus. 4th ed. USA: 
Lippincott Williams & Wilkins 2004.p.587-91.
4. Gupta N, Sharma P. Esophageal diseases. In: Classen M, 
Tytgat G, Lightdale CJ, eds. Gastroenterological Endoscopy. 
2nd ed. New York: Thieme 2010.p.489-90.
5. Yakoob J, Jafri W, Abid S, Jafri N, Islam M, Hamid S, et al. 
Candida esophagitis: risk factors in non-HIV population in 
Pakistan. World J Gastroenterol 2003;9:2328-31.
6. Klieman DA, Pasqualotto AC, Falavigna M, Giaretta T, Severo 
LC. Candida esophagitis: species distribution and risk factors 
for infection. Rev Inst Med Trop S Paulo 2008;50:261-3.
Volume 12, Number 2, August 2011 99
Candida Esophagitis: A Retrospective Study of Upper Gastrointestinal Endoscopic Grading and the Characteristic Profile
7. Kodsi BE, Wickremesinghe PC, Kozinn PJ, Iswara K, 
Goldberg PK. Candida esophagitis: a prospective study of 
27 cases. Gastroenterology 1976;71:715-9.
8. Esophageal candidiasis. In: Hospenthal DR, Rinaldi MG, eds. 
Diagnosis and Treatment of Human Mycosis. USA: Humana 
Press 2008.p.142-3.
9. Al Mofleh IA, Al Mofarreh MA. Esophageal candidiasis 
among a dyspeptic population. Saudi J Gastroenterol 
1999;5:61-5.
10. Vazquez JA. Therapeutic options for the management of 
oropharyngeal and esophageal candidiasis in HIV/AIDS 
patients. HIV Clin Trials 2000;1:47-59.
11. Gandhi BV, Bahadur MM, Dodeja H, Aggrwal V, Thamba 
A, Mali M. Systemic fungan infection in renal diseases. 
J Postgrad Med 2005;51:30-6.
12. Esophageal Infections. In: Mitchell CW, Howes S, eds. 
Manual of Gastroenterology: Diagnosis and Therapy. 4th ed. 
USA: Lippincott Williams & Wilkins 2008.p.117-8.
13. Benhardt J, Herman D, Sheridan M, Calderone R. Adherence 
and invasion studies of Candida albicans strains, using 
in vitro models of esophageal candidiasis. J Infect Dis 
2001;184:1170-5.
14. Al-Shawwa B, D’Andrea L, Quintero D. Candida esophageal 
perforation and esophagopleural fistula: a case report. J Med 
Case Reports 2008;2:209.
15. Sathyanarayanan V, Razak A, Prabhu MM, Saravu K, Pai G, 
Rao AK. A case report of herpetic and candidal esophagitis 




Division of Gastroenterology, Department of Internal Medicine 
Dr. Cipto Mangunkusumo General National Hospital 
Jl. Diponegoro No. 71 Jakarta 10430 Indonesia 
Phone: +62-21-3153957 Facsimile: +62-21-3142454 
E-mail: marcellus_sk@yahoo.com
